IGC Pharma
IGC
#10740
Rank
NZ$37.14 M
Marketcap
NZ$0.32
Share price
-4.61%
Change (1 day)
-46.81%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

EPS for IGC Pharma (IGC)

EPS in 2026 (TTM): NZ-$0.15

According to IGC Pharma's latest financial reports the company's current EPS (TTM) is NZ-$0.16. In 2025 the company made an earnings per share (EPS) of NZ-$0.16 an increase over its 2024 EPS that were of NZ-$0.40.

EPS history for IGC Pharma from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.15-4.82%
2025NZ-$0.16-59.09%
2024NZ-$0.40-0%
2023NZ-$0.40-26.67%
2022NZ-$0.5442.86%
2021NZ-$0.3810.53%
2020NZ-$0.3446.15%
2019NZ-$0.24116.67%
2018NZ-$0.11-14.29%
2017NZ-$0.13-58.82%
2016NZ-$0.31-45.16%
2015NZ-$0.56-16.22%
2014NZ-$0.6715.62%
2013NZ-$0.58-87.97%
2012NZ-$4.81-80.15%
2011NZ-$24.24219.05%
2010NZ-$7.60740%
2009NZ-$0.90-91.8%
2008NZ-$11.03-654.55%
2007NZ$1.99-178.57%
2006NZ-$2.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sterling Infrastructure
STRL
NZ$32.70-20,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
NZ$7.40-4,644.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
NZ-$10.96 6,633.33%๐Ÿ‡บ๐Ÿ‡ธ USA